Hospital injectables and CNS medicines manufacturer with European manufacturing footprint
Ethypharm manufactures injectable and oral pharmaceutical products for hospital and critical-care settings, operating six production sites across France, Spain, the UK, and China. The stack reveals heavy reliance on manufacturing-specific systems (LIMS, SCADA, MES) paired with SAP and Sage X3 for ERP, indicating tight integration between production control and financial/supply-chain operations—typical of regulated pharma. Active hiring centers on manufacturing and quality roles while tackling pain points around GXP compliance, machine reliability, and network stability, suggesting ongoing industrial modernization efforts.
Ethypharm is a mid-sized, privately held pharmaceutical manufacturer founded in 1977 and headquartered in France. The company operates 1,800 employees across manufacturing (1,400 in industrial operations), sales, quality, and support functions, with direct market presence in 68 countries—primarily Europe and China—and partnership coverage across EMEA, North America, Latin America, and Asia-Pacific. The product portfolio focuses on hospital injectables and central nervous system medicines for severe pain and addiction treatment. Manufacturing capabilities span injectables and complex oral solid forms across six facilities in France, Spain, the UK, and China.
Six production sites located in France, Spain, the United Kingdom, and China, with expertise in hospital injectables and complex oral solid forms. Approximately 1,400 of 1,800 employees work in industrial operations.
Core stack includes LIMS (lab information management), SCADA (industrial control), MES (manufacturing execution), ERP via SAP and Sage X3, and HPLC instrumentation, plus BMS and standard Microsoft Office tools.
Other companies in the same industry, closest in size